#United States #Stryker #Portage #Sonopet 3 #ultrasonic tissue

Stryker Launches Sonopet® 3: A New Era in Ultrasonic Tissue Removal

On October 14, 2026, Stryker, a prominent name in medical technologies, announced the launch of its latest product, the Sonopet® 3. This device marks a significant advancement in the realm of ultrasonic bone and soft tissue removal. Having received FDA 510(k) clearance, the Sonopet 3 is poised to enhance surgical procedures by delivering greater power, precision, and versatility.

The Sonopet 3 was developed following extensive cooperation with surgeons who provided their insights during the design phase. Mitch Foley, Vice President and General Manager of Stryker's Neurosurgical business, emphasized the importance of this collaboration stating, "At Stryker, innovation begins with listening to our customers. Every major advancement in Sonopet 3 can be attributed to surgeon feedback."

Surgeons expressed their needs for improved ergonomics, heightened performance, and better integration capabilities during surgeries. Their feedback has directly influenced the enhancements made in Sonopet 3, ensuring the device can meet the rigorous demands of modern surgical environments effectively.

Revolutionary Features

The Sonopet 3 boasts several advanced technologies, including RISE (Reimagined Integrated Surgical Experience) and Pulse Control. These features are designed to streamline surgical workflows and enhance operating room efficiency. RISE offers a connected surgical workflow that facilitates seamless integration with existing surgical tools and practices, thus supporting the surgical team in a more collaborative manner.

Moreover, Pulse Control allows for more precise regulation during the resection of both hard and soft tissues. This added control means that surgeons can perform complex procedures with greater accuracy and confidence, thereby improving patient outcomes.

Market Impact

With the full commercial launch expected later this fall, the initial clinical procedures using the Sonopet 3 are scheduled to begin in October. This timely rollout indicates Stryker's keen focus on ensuring that healthcare providers have access to this revolutionary technology when they need it most.

As part of its mission to enhance healthcare globally, Stryker's innovations are said to impact over 150 million patients annually. This latest development in the Sonopet series is a testament to Stryker’s commitment to improving not just the tools that surgeons use, but also the overall patient and healthcare outcomes.

The introduction of the Sonopet 3 aligns with Stryker's broader endeavor to create cutting-edge products in fields such as MedSurg and Orthopaedics. Continuing to set new standards in the industry, Stryker is looking ahead to pave the way for future innovations based on the collaborative input of healthcare professionals.

More information about the Sonopet 3 and Stryker's suite of products can be found on their website at www.stryker.com.

Conclusion

Stryker’s Sonopet 3 represents a pivotal advancement in surgical technology. By addressing the specific needs of surgeons and focusing on enhancing performance and integration, Stryker is not just meeting the current demands of healthcare, but also anticipating future needs in the field of surgical procedures. As this technology rolls out, it is set to transform the operating room experience for both surgeons and patients alike.